Cargando…

Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI): protocol for a randomised, controlled, non-inferiority trial

AIM: To evaluate the efficacy and safety of recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) in lowering major adverse cardiovascular and cerebrovascular events (MACCEs) in Chinese acute ST-segment elevation myocardial infarction (STEMI) patients. METHODS AND ANALYSIS: The study i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hai-bo, Ji, Ping, Zhao, Xing-Shan, Xu, Haiyan, Yan, Xiao-Yan, Yang, Qin, Yao, Chen, Gao, Run-Lin, Wu, Yang-feng, Qiao, Shu-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623508/ https://www.ncbi.nlm.nih.gov/pubmed/28928186 http://dx.doi.org/10.1136/bmjopen-2017-016838

Ejemplares similares

The noncatalytic regions of the tyrosine kinase Tnk1 are important for activity and substrate specificity
por: Ahmed, Sultan, et al.
Publicado: (2022)

MOF Regulates TNK2 Transcription Expression to Promote Cell Proliferation in Thyroid Cancer
por: Li, Danyang, et al.
Publicado: (2020)

TNK2 promoted esophageal cancer progression via activating egfr‐akt signaling
por: Zhang, Anqing, et al.
Publicado: (2021)

ACK1/TNK2 Tyrosine Kinase: Molecular Signaling and Evolving Role in Cancers
por: Mahajan, Kiran, et al.
Publicado: (2014)

Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells
por: Mahajan, Nupam P., et al.
Publicado: (2018)

Entry by multiple picornaviruses is dependent on a pathway that includes TNK2, WASL, and NCK1
por: Jiang, Hongbing, et al.
Publicado: (2019)

Fusion crystallization reveals the behavior of both the 1TEL crystallization chaperone and the TNK1 UBA domain
por: Nawarathnage, Supeshala, et al.
Publicado: (2023)

Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design
por: Levin, Bruce, et al.
Publicado: (2011)

Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes
por: Kong, Defeng, et al.
Publicado: (2022)

A Novel Putative Role of TNK1 in Atherosclerotic Inflammation Implicating the Tyk2/STAT1 Pathway
por: Bao, Mei-Hua, et al.
Publicado: (2020)

Rescue thrombolysis for medium vessel occlusion (RESCUE-TNK): Rationale and design of a phase 2 randomized trial
por: Hu, Hai-Zhou, et al.
Publicado: (2023)

TNK2‐AS1 upregulated by YY1 boosts the course of osteosarcoma through targeting miR‐4319/WDR1
por: Yao, Weitao, et al.
Publicado: (2020)

Transcriptional signature of accessory cells in the lateral line, using the Tnk1bp1:EGFP transgenic zebrafish line
por: Behra, Martine, et al.
Publicado: (2012)

TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth
por: Chan, Tsz-Yin, et al.
Publicado: (2021)

The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer
por: Wu, Xinyan, et al.
Publicado: (2016)

TCTAP A-014 Pharmacoinvasive Therapy in Treating Acute STEMI Patients in COVID-19 Era-Thrombolysis by Tenecteplase (TNK) / Streptokinase (STK) Followed by Rescue PCI of the Culprit Vessel
por: Islam, Ahm Waliul, et al.
Publicado: (2023)

TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells
por: Howlin, Jillian, et al.
Publicado: (2008)

Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1
por: Rudd, Meghan L, et al.
Publicado: (2014)

Intra-arterial tenecteplase is safe and may improve the first-pass recanalization for acute ischemic stroke with large-artery atherosclerosis: the BRETIS-TNK trial
por: Zhao, Zi-Ai, et al.
Publicado: (2023)

Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi
por: Whyte, Claire S., et al.
Publicado: (2021)

Intravenous Tenecteplase for Acute Ischemic Stroke Within 4.5–24 Hours of Onset (ROSE-TNK): A Phase 2, Randomized, Multicenter Study
por: Wang, Lu, et al.
Publicado: (2023)

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
por: Chevilley, Arnaud, et al.
Publicado: (2015)

tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022)

Post-synaptic Release of the Neuronal Tissue-Type Plasminogen Activator (tPA)
por: Lenoir, Sophie, et al.
Publicado: (2019)

LncRNA TNK2‐AS1 regulated ox‐LDL‐stimulated HASMC proliferation and migration via modulating VEGFA and FGF1 expression by sponging miR‐150‐5p
por: Cai, Tianzhi, et al.
Publicado: (2019)

The Influence of Tissue Plasminogen Activator I/D Polymorphism on the tPA Response to Exercise
por: COUGHLIN, ADAM M., et al.
Publicado: (2018)

TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability
por: Chouhan, Surbhi, et al.
Publicado: (2022)

Safety and Efficacy of Thrombolytic Therapy Using rt-PA (Alteplase) in Acute Ischemic Stroke
por: Sivanandy, Palanisamy, et al.
Publicado: (2011)

Thrombolytic treatment (alteplase; rt-Pa) in acute massive pulmonary embolism and cardiopulmonary arrest
por: Dirican, Adem, et al.
Publicado: (2014)

Tissue plasminogen activator (tPA) attenuates propofol-induced apoptosis in developing hippocampal neurons
por: Liang, Chao, et al.
Publicado: (2016)

Modulations of the neuronal trafficking of tissue-type plasminogen activator (tPA) influences glutamate release
por: Varangot, Alexandre, et al.
Publicado: (2023)

Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves
por: Kochtebane, Najlah, et al.
Publicado: (2014)

To tPA or Not to tPA: Two Medical-Legal Misadventures of Diagnosing a Cerebrovascular Accident as a Stroke Mimic
por: Moore, Malia J., et al.
Publicado: (2019)

Alu DNA Polymorphism of Human Tissue Plasminogen Activator (tPA) Gene in Diabetic Jordanian Patients
por: Yasin, Salem R., et al.
Publicado: (2019)

Enhanced control of bioactivity of tissue plasminogen activator (tPA) through domain-directed enzymatic oxidation of terminal galactose
por: Mahdi, Wael A., et al.
Publicado: (2022)

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
por: Chapman, Sherita N, et al.
Publicado: (2014)

Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR
por: Bertrand, T, et al.
Publicado: (2015)

Tissue‐type plasminogen activator (tPA) homozygous Tyr471His mutation associates with thromboembolic disease
por: Tao, Yanyi, et al.
Publicado: (2023)

l-Palmitoylcarnitine potentiates plasmin and tPA to inhibit thrombosis
por: Yang, Juan, et al.
Publicado: (2023)

Double-Gene Copromoting Expression Analysis in tPA/GH Transgenic Goat Mammary Epithelial Cells and Thrombolytic Activity of tPA In Vitro
por: Song, Shaozheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i7cb5ro7tfa5obs411q3f0fvsm